Axon Plunged To a 2-Year Low. Here's Why It Could Be a Golden Buying Opportunity

Axon Enterprise stock tumbled 18% after missing Q3 revenue estimates due to a delayed $30 million Federal Dedrone deployment. The company also cut free cash flow guidance and reported weak Taser sales, but management emphasized underlying demand remains strong. Despite the sell-off, analysts view the stock as potentially undervalued given its historical growth trajectory and solid business fundamentals.